Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

Gastroenterology

Volumn 107, Issue 4, 1994, Pages 1183-1188

  Eberhart, Charles E ^a   Coffey, Robert J ^a   Radhika, Aramandla ^a   Giardiello, Francis M ^b   Ferrenbach, Suzanne ^a   Dubois, Raymond N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ISOENZYME; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; POLYADENYLATED RNA; PROSTAGLANDIN SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RECTUM ADENOMA;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; BASE SEQUENCE; BLOTTING, NORTHERN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; ISOENZYMES; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027993458     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(94)90246-1     Document Type: Article

References (53)

1. Aspirin use and reduced risk of fatal colon cancer
2. Aspirin use and risk of fatal cancer
3. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
4. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme
5. Aspirin use, cancer, and polyps of the large bowel
6. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group
7. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
8. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
9. Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis
10. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment
11. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
12. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration
13. Effects of long-term sulindac therapy on colonic polyposis
14. Sulindac for polyposis of the colon
15. Sulindac for polyposis of the colon
16. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with d.l-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet
17. Effects of aspirin on 1,2-dimethylhy-drazine-induced colonic carcinogenesis
18. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
19. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination
20. Piroxicam decreases postirradiation colonic neoplasia in the rat
21. A protective effect of sulindac against chemically-induced primary colonic tumours in mice
22. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development
23. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds
24. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat
25. Eicosanoids enhance epidermal growth factor receptor activation and proliferation in glomerular epithelial cells
26. 2, prostaglandins, and mesangial cell proliferation
27. 2α
28. Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis
29. Effects of eicosanoid metabolism inhibitors on growth of a human gastric tumour cell line (HGT)
30. 2 and rat liver regeneration
31. Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response
32. 2 and the alpha subtype of protein kinase C
33. Indomethacin inhibits cell proliferation in the oxyntic epithelium of the rat
34. 2 prostaglandins modulate cell proliferation in the small intestinal epithelium of the rat
35. Regulation of proliferation of rat mammary tumor cells by inhibitors of cyclooxygenase and lipoxygenase
36. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing
37. Prostaglandins from tumours of human large bowel
38. 2 in human colonic tissue using a chemiluminescence enzyme immunoassay with catalase as labeling enzyme
39. Leukotriene synthesis by human gastrointestinal tissues
40. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues
41. 2 by tissue-fixed macrophages in colonic carcinoma
42. Altered eicosanoid levels in human colon cancer
43. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
44. Towards a better aspirin
45. Aspirin and the potential role of prostaglandins in colon cancer
46. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester
47. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
48. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
49. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose
50. Human cyclooxygenase-2 cDNA
51. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I
52. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose
53. The molecular genetics of colorectal neoplasia